Jun Yang @Junjyang

Pharmacologist and geneticist through and through Tennessee, USA Joined October 2009

Tweets

569
Followers

924
Following

591
Likes

770

UChicago Leukemia Program @UChicagoLeuk

2 months ago

new research featuring @DrWendyStock @CanerSaygin as co-authors looking at BH3 mimetics in T-cell ALL! pubmed.ncbi.nlm.nih.gov/41995729/

0 3 8 444 2

View Details

Jun Yang @Junjyang

7 months ago

Look forward to seeing everyone in a few hrs, ASH workshop on functional precision medicine #ASH2025 @ASH_hematology @StJudeResearch @StJude

0 0 2 244 0

View Details

Anirban Maitra @Aiims1742

10 months ago

This is HUGE! No embargo needed for @AACR publications deposited in PubMed Central - enabling compliance with the NIH public access policy without spending exorbitant open access fees.

Elizabeth McKenna @ElizSMcKenna

10 months ago

You can read the AACR journals' policy here: aacrjournals.org/pages/open-acc… "The Author Accepted Manuscript is permitted to be deposited in PMC and made available to the public on or after the first online publication date of the Version of Record."

1 7 33 13K 1

1 16 79 9K 5

View Details

Jun Yang @Junjyang

11 months ago

New paper alert! Our team published in @NatureComms on MeiHMM - a hidden Markov model that identifies meiotic nondisjunction error types in chromosomal abnormalities, like Down Syndrome, without parental data! #ComputationalBiology @StJudeResearch doi.org/10.1038/s41467…

1 3 13 530 2

View Details

Jun Yang @Junjyang

11 months ago

Kudos to @maud_maillard on her new paper in @jclinicalinvest! Our findings indicate NUDT5 is a key regulator of thiopurine metabolism, offering new insights into how cells strike the balance between de novo vs salvage purine synthesis.

Journal of Clinical Investigation @jclinicalinvest

11 months ago

Thiopurines for the treatment of cancer or autoimmune disease are limited by their toxicity. @MaudMaillard @Junjyang @StJudeResearch identify germline NUDT5 variants that affect thiopurine metabolism and cytotoxicity in children with ALL, having implications for individualized

1 4 7 2K 1

0 1 9 557 1

View Details

Jun Yang @Junjyang

11 months ago

@LBastian_MD @BloodPortfolio Thanks for writing the editorial piece! A lot more to learn about this drug!@StJudeResearch @StJude

0 0 1 71 0

View Details

Jun Yang @Junjyang

a year ago

One of my favorite meetings!

ESH (Haematology) @ESHaematology

a year ago

We are a go! #ESHALL2025 started this morning! We are happy to welcome participants in Malahide for the 2,5-day ESH 4th Translational Research Conference on ALL More information➡ bit.ly/4cy9jAS Chairs: @kathrinbernt @CoolsJn @DombretHerve @ullawk #ESHCONFERENCES #LEUsm

0 1 8 957 1

1 0 2 258 0

View Details

Jun Yang @Junjyang

a year ago

@ADurbinLab @StJudeResearch @MolOnc_StJude @JunQiLab @TheAbraLab Congrats, Adam!

0 0 2 58 0

View Details

Rosa Ritunnano @RRitunnano

2 years ago

Instead of listing my publications, as the year draws to an end, I want to put pressure on the commonplace assumption that productivity must always increase. Good research is disruptive and thinking time is central to high quality scholarship and necessary for disruptive research

52 1K 5K 384K 1K

View Details

Jun Yang @Junjyang

2 years ago

#PGRN poster session at John Dutton’s ranch next year? @pgrnhub @ericawoodahl @MinoliPereraPgx

0 0 6 255 0

View Details

Jun Yang @Junjyang

2 years ago

@KaiTanLab1 @NatureCancer @Changya1 @CMullighan Glad to help and to be part of this cool project!

0 0 0 86 0

View Details

Jun Yang @Junjyang

2 years ago

Why is #ALL highly curable in #kids but carries a much worse prognosis in #adults?? Check out our new paper @JCO_ASCO describing genomics of age-related differences in ALL drug sensitivity @StJudeResearch @MDAndersonNews @UChicagoLeuk @NitinJainMD

St. Jude Research @StJudeResearch

2 years ago

Researchers identified distinct molecular subtypes of B-ALL that occur in different age groups explaining why cure rates vary between children and adults. The study suggests treatments should be tailored based on underlying molecular groups beyond age. ow.ly/k2SL50SSlU2

0 7 18 4K 2

0 7 36 3K 4

View Details

Jun Yang @Junjyang

2 years ago

@Richardson_S_E Congrats! Thanks for stopping by Carolin’s poster last nite.

0 0 0 75 0

View Details

Jun Yang @Junjyang

2 years ago

@AdeleKFielding @hermione_allen @EHA_Hematology I stopped by your posters last nite, beautiful work!

0 0 0 186 0

View Details

Jun Yang @Junjyang

2 years ago

In beautiful #Madrid for #EHA2024 @EHA_Hematology rooting for Carolin and her poster presentation re inotuzumab resistance in B-ALL

0 1 15 754 1

View Details

Jun Yang @Junjyang

2 years ago

@NitinJainMD @mkonople @EHA_Hematology Thank you @NitinJainMD for picking the nice location and food! #granvia #Madrid

0 0 2 61 0

View Details

Jun Yang @Junjyang

2 years ago

@Rybak_JM Fantastic!!

0 0 0 112 0

View Details

Jun Yang @Junjyang

2 years ago

@KaiTanLab1 @CellCellPress @LingQin6 @pillai_vinodh Really cool stuff! @KaiTanLab1

0 0 0 107 0

View Details

Jun Yang @Junjyang

2 years ago

@AshKishtagari @RaviBha65448036 @JCO_ASCO Very cool study!

0 0 0 30 0

View Details

St. Jude Research @StJudeResearch

2 years ago

Congratulations to Ching-Hon Pui, MD, for receiving the @AACR-@StBalrdricks Foundation Award for Outstanding Achievement in Pediatric Cancer Research. Your pioneering research is lifesaving, and your commitment is inspiring. ow.ly/EzF250Ra17K #AACR24